Sylvain Fisson

Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.

Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation.

Identification of new CNS-resident macrophage subpopulation molecular markers for the discrimination with murine systemic macrophages.

Natural regulatory T cells control the development of atherosclerosis in mice.

Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire.

Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen.

Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors.

Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.

Animal models of intraocular lymphomas.

Selective expression of inhibitory Fcgamma receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response.

The future of primary intraocular lymphoma (retinal lymphoma).

Immune infiltration in human cancer: prognostic significance and disease control.

Tumor microenvironment is multifaceted.

The immune microenvironments of lung and intraocular tumors.

Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma.

Murine models of B-cell lymphomas: promising tools for designing cancer therapies.

Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.

Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.

Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment.

Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.

Herpesvirus detection and cytokine levels (IL-10, IL-6, and IFN-γ) in ocular fluid from Tunisian immunocompetent patients with uveitis.

Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.

Mouse models of primary central nervous system lymphomas: tools for basing funding and therapeutic strategies.

Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells.

ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis.